Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.46 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 6/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1592226 | 0.98 | DGKA (0.50) | DGKACAMK2ANAAAACHEHTR2C | |
| SCHEMBL114260 | 0.95 | DGKA (0.52) | DGKANAAAACHEHTR2CMGLL | |
| SCHEMBL821994 | 0.95 | DGKA (0.46) | DGKANAAAACHEHTR2CMGLL | |
| SCHEMBL17589192 | 0.93 | DGKA (0.56) | DGKANAAAACHEHTR2CPRSS1 | |
| SCHEMBL6057011 | 0.93 | DGKA (0.56) | DGKANAAAACHEHTR2CPRSS1 | |
| SCHEMBL822404 | 0.93 | DGKA (0.56) | DGKANAAAACHEHTR2CPRSS1 | |
| SCHEMBL22551458 | 0.93 | DGKA (0.56) | DGKANAAAACHEHTR2CPRSS1 | |
| SCHEMBL21143360 | 0.93 | DGKA (0.50) | DGKANAAAACHEHTR2CMGLL | |
| SCHEMBL21143375 | 0.93 | DGKA (0.56) | DGKANAAAACHEHTR2CPRSS1 | |
| SCHEMBL7262397 | 0.93 | DGKA (0.56) | DGKANAAAACHEHTR2CPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10322988-B2 | Process for purifying a stream comprising 1,4-butanediol | JOHNSON MATTHEY DAVY TECHNOLOGIES LIMITED (GB) | 2019-06-18 | — | — | US | claimed |
| EP-2753597-B1 | PROCESS FOR PURIFYING A STREAM COMPRISING 1,4-BUTANEDIOL | JOHNSON MATTHEY DAVY TECHNOLOGIES LTD (GB) | 2018-10-17 | — | — | EP | claimed |
| CN-103796981-B | The method of the stream that purifying comprises BDO | JOHNSON MATTHEY DAVY TECHNOLOGIES LTD. (GB) | 2016-05-18 | — | — | CN | claimed |
| US-20140350308-A1 | Process For Purifying a Stream Comprising 1,4-Butanediol | JOHNSON MATTHEY DAVY TECHNOLOGIES LIMITED (GB) | 2014-11-27 | — | — | US | claimed |
| CN-103796981-A | Process for purifying a stream comprising 1,4-butanediol | DAVY PROCESS TECHN LTD | 2014-05-14 | — | — | CN | claimed |
| WO-2013034881-A1 | PROCESS FOR PURIFYING A STREAM COMPRISING 1,4- BUTANEDIOL | DAVY PROCESS TECHNOLOGY LIMITED (GB) | 2013-03-14 | — | — | WO | claimed |
| US-20250162967-A1 | PROCESS FOR PRODUCING A REFINED 1,4-BUTANEDIOL STREAM | JOHNSON MATTHEY DAVY TECHNOLOGIES LIMITED (GB) | 2025-05-22 | — | — | US | disclosed |
| EP-4490137-A1 | PROCESS FOR PRODUCING A REFINED 1,4-BUTANEDIOL STREAM | Johnson Matthey Davy Technologies Limited (GB) | 2025-01-15 | — | — | EP | disclosed |
| CN-118696022-A | Method for producing a purified 1, 4-butanediol stream | 庄信万丰戴维科技有限公司 | 2024-09-24 | — | — | CN | disclosed |
| WO-2023170409-A1 | PROCESS FOR PRODUCING A REFINED 1,4-BUTANEDIOL STREAM | JOHNSON MATTHEY DAVY TECHNOLOGIES LIMITED (GB) | 2023-09-14 | — | — | WO | disclosed |
| US-10322988-B2 | Process for purifying a stream comprising 1,4-butanediol | JOHNSON MATTHEY DAVY TECHNOLOGIES LIMITED (GB) | 2019-06-18 | — | — | US | disclosed |
| US-10322988-B2 | Process for purifying a stream comprising 1,4-butanediol | JOHNSON MATTHEY DAVY TECHNOLOGIES LIMITED (GB) | 2019-06-18 | — | — | US | disclosed |
| EP-2753597-B1 | PROCESS FOR PURIFYING A STREAM COMPRISING 1,4-BUTANEDIOL | JOHNSON MATTHEY DAVY TECHNOLOGIES LTD (GB) | 2018-10-17 | — | — | EP | disclosed |
| CN-103796981-A | Process for purifying a stream comprising 1,4-butanediol | DAVY PROCESS TECHN LTD | 2014-05-14 | — | — | CN | disclosed |
| CN-103044197-A | Technological method for purifying1,4-butanediol and co-producing gamma-butyrolactone | CHINA PETROLEUM & CHEMICAL | 2013-04-17 | — | — | CN | disclosed |
| WO-2013034881-A1 | PROCESS FOR PURIFYING A STREAM COMPRISING 1,4- BUTANEDIOL | DAVY PROCESS TECHNOLOGY LIMITED (GB) | 2013-03-14 | — | — | WO | disclosed |
| WO-2013034881-A1 | PROCESS FOR PURIFYING A STREAM COMPRISING 1,4- BUTANEDIOL | DAVY PROCESS TECHNOLOGY LIMITED (GB) | 2013-03-14 | — | — | WO | disclosed |
| CN-1183081-C | Preparation of 1, 4-butanediol | �����ɷ� | 2005-01-05 | — | — | CN | disclosed |
| US-6350924-B1 | Method for producing 1,4-butanediol | BASF AKTIENGESELLSCHAFT (DE) | 2002-02-26 | — | — | US | disclosed |
| CN-1298381-A | Method for producing 1,4-butanediol | BASF AG (DE) | 2001-06-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250162967-A1 | PROCESS FOR PRODUCING A REFINED 1,4-BUTANEDIOL STREAM | HSD17B7, ADH1C, SORD | DGKA 680/4885CAMK2A 3027/4885NAAA 4475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.